Suppression of the proliferation of cancer cell lines, KB-3-1 and K562 cells preceded by a decrease in intracellular

Xiao-Fang Che1, Shin-ichi Akiyama, Akio Tomoda

  • 1Department of Molecular Oncology, Advanced Therapeutics, Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan.

Oncology Reports
|April 22, 2008
PubMed

Insights

Phenoxazine derivatives, Phx-3 and Phx-1, lower cancer cell intracellular pH (pHi), suppressing proliferation. Phx-3 demonstrated greater efficacy in reducing pHi and inhibiting cancer cell growth.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Cancer cells, including KB-3-1 and K562 lines, exhibit higher intracellular pH (pHi) than normal cells.
  • Maintaining a specific pHi is crucial for cellular homeostasis and function.

Purpose of the Study:

  • To investigate the effect of phenoxazine derivatives (Phx-3 and Phx-1) on the intracellular pH of cancer cells.
  • To evaluate the anti-proliferative potential of these compounds and their correlation with pHi changes.

Main Methods:

  • Treatment of KB-3-1 and K562 cancer cell lines with varying concentrations of Phx-3 and Phx-1.
  • Measurement of intracellular pH (pHi) changes using pH-sensitive probes.
  • Assessment of cell proliferation and apoptosis 24 hours post-treatment.

Main Results:

  • Both Phx-3 and Phx-1 significantly decreased cancer cell pHi in a dose-dependent manner within 20 minutes.
  • Phx-3 induced a more substantial pHi reduction (0.9 units) compared to Phx-1 (0.4 units).
  • Phx-3 and Phx-1 exhibited dose-dependent anti-proliferative effects, with Phx-3 showing significantly greater efficacy against KB-3-1 and K562 cells.

Conclusions:

  • The anti-cancer effects of Phx-3 and Phx-1 are strongly associated with their ability to induce intracellular acidification in cancer cells.
  • This pHi decrease may disrupt intracellular homeostasis, leading to suppressed proliferation and potentially apoptosis.
  • Phenoxazine derivatives show promise as anti-cancer agents by targeting cancer cell pH regulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...